Advertisement

Reactions Weekly

, Volume 1756, Issue 1, pp 172–172 | Cite as

Hydrocortisone/prednisolone

Pneumocystis jirovecii pneumonia: 2 case reports
Case report
  • 7 Downloads
Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

  • * death

  • * life-threatening

  • * hospitalisation

  • * disability

  • * congenital anomaly

  • * other medically important event

A 1-year-old boy and an 8-month-old boy developed Pneumocystis jirovecii pneumonia (PJP) during treatment with prednisolone or hydrocortisone for pericardiotomy syndrome or hypoglycaemia [time to reaction onsets not stated].

Case 1: A 1-year-old boy, who was diagnosed with pericardiotomy syndrome at the age of 6 months, started receiving IV prednisolone 1.2 mg/kg/day from the age of 7 months and was scheduled for 5 months. He required positive pressure ventilation by continuous positive airway pressure (CPAP) for tracheomalacia. Nine months later, CPAP was changed to high flow nasal cannula (HFNC), and he was hospitalised for a long period of time in the neonatal ICU due to respiratory symptoms of unknown aetiology. An infection was suspected due to a chief complaint was...

Reference

  1. Takei H, et al. Two pediatric cases of Pneumocystis jirovecii pneumonia diagnosed by polymerase chain reaction of gastric lavage. Journal of Infection and Chemotherapy 25: 477-479, No. 6, Jun 2019. Available from: URL: http://doi.org/10.1016/j.jiac.2019.01.016 - JapanCrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations